Hans Hull's Net Worth

$6.74 Million

Estimate Recalculated Nov 1, 2024 02:19PM EST

Who is Hans Hull

Hans Hull has an estimated net worth of $6.74 Million. This is based on reported shares across multiple companies, which include PLIANT THERAPEUTICS, INC., and Avalanche Biotechnologies, Inc..

SEC CIK

Hans Hull's CIK is 0001614876

Past Insider Trading and Trends

2015 was Hans Hull's most active year for acquiring shares with 7 total transactions. Hans Hull's most active month to acquire stocks was the month of December. 2015 was Hans Hull's most active year for disposing of shares, totalling 8 transactions. Hans Hull's most active month to dispose stocks was the month of July. 2023 saw Hans Hull paying a total of $58,029.28 for 195,325 shares, this is the most they've acquired in one year. In 2015 Hans Hull cashed out on 77,300 shares for a total of $1,291,205.17, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PLIANT THERAPEUTICS, INC.

Chief Business Officer
Updated Jul 12, 2024
Form 4
-4.17%
-9.90K
$11.56
-$114.44K
Jul 12, 2024
259.29K
Sale
ScheduledJul 10
Form 4
8.87%
19.34K
Jul 11, 2024
269.19K
Grant
Jul 09
Form 4
51.06%
94.50K
Jan 24, 2024
311.36K
Grant
Jan 23
Form 4
-5.02%
-9.79K
$17.23
-$168.61K
Jan 19, 2024
216.86K
Sale
ScheduledJan 17
Form 4
-11.99%
-31.32K
$12.35
-$604.55K
Aug 07, 2023
258.01K
Sale
Aug 03 - Aug 04
Form 4
-7.56%
-17.94K
$18.01
-$323.03K
Jul 19, 2023
250.97K
Sale
Jul 17
Form 4
17.41%
35.16K
Jul 18, 2023
268.91K
Grant
Jul 14
Form 4
-4.28%
-9.04K
$26.52
-$239.64K
Apr 03, 2023
233.76K
Sale
Mar 30
Form 4
9.09%
17.58K
Mar 31, 2023
242.79K
Grant
Mar 29
Form 4
94.22%
130.20K
Jan 27, 2023
300.18K
Grant
Jan 25
Form 4
6.83%
8.83K
$19.10
-$167.11K
Dec 21, 2022
169.98K
Grant
Dec 19 - Dec 20
Form 4
112.50K
Feb 02, 2022
112.50K
Grant
Jan 26
Form 4
$2.08
$9.36K
May 28, 2021
170.02K
Options
May 26
Form 4
62.25K
Jan 26, 2021
62.25K
Grant
Jan 23
Form 4
$2.08
$7.28K
Jan 04, 2021
170.02K
Options
Dec 30
Form 4
28.91%
42.93K
$13.08
$357.49K
Jun 09, 2020
219.39K
Options
Feb 28 - Jun 05
Form 3
Jun 02, 2020
140.14K
Showing 17 results

Avalanche Biotechnologies, Inc.

Chief Executive Officer
Updated Aug 25, 2015
Form 4
599.34%
117.59K
Aug 25, 2015
137.21K
Grant
Aug 21
Form 4
$0.19
$1.58K
Jun 16, 2015
31.82K
Options
Jun 12
Form 4
-5.91%
-2.00K
$18.92
-$74.90K
Jun 05, 2015
31.82K
Sale
ScheduledJun 04
Form 4
-12.88%
-5.00K
$15.53
-$153.40K
May 06, 2015
33.82K
Sale
ScheduledMay 04
Form 4
933.73%
31.00K
Apr 23, 2015
34.32K
Grant
Apr 21
Form 4
-47.15%
-27.50K
$19.40
-$1.06M
Apr 08, 2015
30.82K
Sale
ScheduledApr 07
Form 4
Aug 07, 2014
3.32K
Options
Aug 05
Form 4
75.00K
Aug 01, 2014
75.00K
Grant
Jul 30
Form 3
Jul 30, 2014
Showing 9 results